13-valent pneumococcal conjugate vaccine in Africa
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.
The 7-valent pneumococcal conjugate vaccine (PCV7) has been shown to be highly cost-effective. The 13-valent pneumococcal conjugate vaccine (PCV13) offers seroprotection against six additional serotypes. A decision-analytic model was constructed to estimate direct medical costs and clinical effectiveness of PCV13 vaccination on invasive pneumococcal disease (IPD), pneumonia, and otitis media re...
متن کاملImpacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
Applications of the heptavalent pneumococcal conjugate vaccine (PCV7) in the pediatric immunization schedule have dramatically reduced the incidence of pneumococcal diseases in both vaccinated children and unvaccinated individuals of all ages. However, increased infections caused by non-PCV7 serotypes have been reported by several groups. To overcome this problem, new vaccines covering more ser...
متن کاملInvasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
OBJECTIVE To examine whether there is a different clinical profile and severity of invasive pneumococcal disease (IPD) in children caused by nonvaccine types in the era of 13-valent pneumococcal conjugate vaccine (PCV13). METHODS Observational study of childhood IPD in Massachusetts based on state public health surveillance data comparing pre-PCV13 (2007-2009) and post-PCV13 (2010-2012) eras....
متن کامل647Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
647. Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States Lindsay Kim, MD, MPH; Thomas H. TaylorJr., PE, MS; Tracy Pondo, MSPH; Monica M. Farley, MD; William Schaffner, MD; Arthur Reingold, MD; Ann Thomas, MD, MPH; Lee Harrison, MD MPH; Ruth Lynfield, MD; Nancy M. Bennett, MD; Susan Petit, MPH; Lisa Miller,; Megin Nichols, MD, MSPH; Lesley Mcg...
متن کاملImpact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.
BACKGROUND The impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal meningitis (PM) in US children is unknown. We compared the serotype distribution, antibiotic susceptibility, hospital course, and outcomes of children with PM 3 years before and 3 years after the introduction of PCV13. METHODS We identified patients ≤ 18 years of age with PM at 8 children's hospitals in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Global Health
سال: 2017
ISSN: 2214-109X
DOI: 10.1016/s2214-109x(17)30044-x